Larsen P D, Kerr A J, Hood M, Harding S A, Hooks D, Heaven D, Lever N A, Sinclair S, Boddington D, Tang E W, Swampillai J, Stiles M K
Department of Surgery and Anaesthesia, University of Otago, Wellington, NZ.
Cardiology Department, Middlemore Hospital, Auckland, NZ.
Heart Lung Circ. 2017 Mar;26(3):235-239. doi: 10.1016/j.hlc.2016.06.1206. Epub 2016 Jul 19.
The New Zealand Cardiac Implanted Device Registry (Device) has recently been developed under the auspices of the New Zealand Branch of the Cardiac Society of Australia and New Zealand. This study describes the initial Device registry cohort of patients receiving a new pacemaker, their indications for pacing and their perioperative complications.
The Device Registry was used to audit patients receiving a first pacemaker between 1 January 2014 and 1 June 2015.
We examined 1611 patients undergoing first pacemaker implantation. Patients were predominantly male (59%), and had a median age of 70 years. The most common symptom for pacemaker implantation was syncope (39%), followed by dizziness (30%) and dyspnoea (12%). The most common aetiology for a pacemaker was a conduction tissue disorder (35%), followed by sinus node dysfunction (22%). Atrioventricular (AV) block was the most common ECG abnormality, present in 44%. Dual chamber pacemakers were most common (62%), followed by single chamber ventricular pacemakers (34%), and cardiac resynchronisation therapy - pacemakers (CRT-P) (2%). Complications within 24hours of the implant procedure were reported in 64 patients (3.9%), none of which were fatal. The most common complication was the need for reoperation to manipulate a lead, occurring in 23 patients (1.4%).
This is the first description of data entered into the Device registry. Patients receiving a pacemaker were younger than in European registries, and there was a low use of CRT-P devices compared to international rates. Complications rates were low and compare favourably to available international data.
新西兰心脏植入设备注册库（该注册库）最近在澳大利亚和新西兰心脏学会新西兰分会的支持下建立。本研究描述了接受新型起搏器的注册库初始队列患者、他们的起搏适应证以及围手术期并发症。
该设备注册库用于审核2014年1月1日至2015年6月1日期间接受首例起搏器植入的患者。
我们研究了1611例接受首例起搏器植入的患者。患者以男性为主（59%），中位年龄为70岁。起搏器植入最常见的症状是晕厥（39%），其次是头晕（30%）和呼吸困难（12%）。起搏器最常见的病因是传导组织疾病（35%），其次是窦房结功能障碍（22%）。房室传导阻滞是最常见的心电图异常，占44%。双腔起搏器最常见（62%），其次是单腔心室起搏器（34%）和心脏再同步化治疗起搏器（CRT-P）（2%）。64例患者（3.9%）报告了植入手术后24小时内的并发症，均无致命情况。最常见的并发症是需要再次手术调整导线，23例患者（1.4%）出现此情况。
这是对录入该设备注册库数据的首次描述。接受起搏器治疗的患者比欧洲注册库中的患者年轻，与国际数据相比，CRT-P设备的使用率较低。并发症发生率较低，与现有的国际数据相比具有优势。
